Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
<p>Abstract</p> <p>Background</p> <p>Ugandan national guidelines recommend initiation of combination antiretroviral therapy (cART) at CD4<sup>+</sup> T cell (CD4) count below 350 cell/μl, but the implementation of this is limited due to availability of medic...
Saved in:
Main Authors: | Sempa Joseph (Author), Ssennono Mark (Author), Kuznik Andreas (Author), Lamorde Mohammed (Author), Sowinski Stefanie (Author), Semeere Aggrey (Author), Hermans Sabine (Author), Castelnuovo Barbara (Author), Manabe Yukari C (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2012-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda
by: Andreas Kuznik, et al.
Published: (2012) -
Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda
by: Stergachis Andy, et al.
Published: (2009) -
Hypertension and associated risk factors in individuals infected with HIV on antiretroviral therapy at an urban HIV clinic in Uganda
by: Aggrey S Semeere, MMed MAS, et al.
Published: (2014) -
Patient and health system level barriers to and facilitators for tuberculosis treatment initiation in Uganda: a qualitative study
by: Stella Zawedde-Muyanja, et al.
Published: (2022) -
Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda
by: Stella Zawedde-Muyanja, et al.
Published: (2020)